Skip to main content

AbbVie Inc. statistics

  • ABBV · NYSE
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$295.03+0.20%Close 13 Nov 2026 · Market value $525.9B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

AbbVie Inc. is valued at $525.9B on its latest close. Its price is 51.1 times its earnings.

Market value$525.9B
Enterprise value$591.7B
Price / earnings51.07
Price / sales7.97
EV / EBITDA20.44
EV / sales8.96
Price / free cash flow27.87
Price / free cash flow, own 5-year average16.12
EV / EBIT28.07
EV / free cash flow31.58
Free cash flow yield3.6%
Dividend yield2.3%

Share price

Latest close$295.03
Day's change+0.2%
52-week high$302.93
52-week low$190.75
From 52-week high−2.6%
Return · 1 month+3.4%
Return · 3 months+12.7%
Return · year to date+29.1%
Return · 1 year+26.5%
Beta · 1 year against the S&P 500−0.02
50-day average$275.51
200-day average$240.79
RSI 1462.6
Average volume · 20 sessions5.2M

Margins and returns

For fiscal 2025, as filed.

Gross margin70.2%
Operating margin24.6%
Net margin6.9%
Free cash flow margin29.1%
Return on assets7.2%
Return on invested capital9.5%
Return on invested capital, 5-year average10.3%
Return on capital employed16.1%
Stock-based compensation / revenue1.6%

Financial position

At the end of fiscal 2025.

Cash and equivalents$5.23B
Total debt$68.38B
Net debt$63.12B
Current ratio0.67
Quick ratio0.56
Net debt / EBITDA2.72
Interest coverage5.21

Growth

Revenue, latest quarter on a year+10.3%
Revenue, twelve months on a year+10.7%
EPS, latest quarter on a year+2270%
EPS, twelve months on a year+338%
Revenue, 5-year compound+6.0%
Revenue, 10-year compound+10.3%
Net income, 5-year compound−1.8%
Free cash flow, 5-year compound+1.2%
EPS, 5-year compound−2.8%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares1.8B
Shares outstanding, 5-year compound+1.2%
Net share repurchases$808.0M
Dividends per share$6.65
Dividend payout276%

Taxes

For fiscal 2025, as filed.

Income tax expense$2.36B
Effective tax rate35.8%

ABBV in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.